Current Opinion in Oncology

Papers
(The H4-Index of Current Opinion in Oncology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?64
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy46
Collecting information from all sarcoma reference cancer centres worldwide: achievement and next steps42
Role of PSMA PET/CT in imaging and management of prostate cancer36
The role of signaling lymphocyte activation molecule family receptors in hematologic malignancies31
Treatments and challenges in advanced prostate cancer29
Editorial introductions24
Content features and its implementation in novel app-based psycho-oncological interventions for cancer survivors: a narrative review24
State of the art and upcoming trends in HER2-directed therapies in gastrointestinal malignancies22
First and further-line multidisciplinary treatment of retroperitoneal sarcomas21
Harnessing dendritic cells for innovative therapeutic cancer vaccines21
Epigenetic dynamics of aging and cancer development: current concepts from studies mapping aging and cancer epigenomes20
Progress in diagnosis and treatment of checkpoint inhibitor pneumonitis20
Psycho-oncology interventions focusing on fatigue and sleep disturbances18
Beyond ‘the good, the bad and the ugly’: let us put rectal cancer patients at the centre of the decision making17
Neurorehabilitation in brain tumours: evidences and suggestions for spreading of knowledge and research implementation17
Biomarkers and immunotherapy: where are we?16
0.14066386222839